Cargando…

Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India

CONTEXT: COVID-19 pandemic continues to be a serious threat to humanity even after the last 2.5 years and multiple reported waves. Post-COVID-19 cognitive impairment has a detrimental effect on the quality of life, education, occupation, psychosocial as well as adaptive functioning and independence....

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Sanat Kumar, Khanna, Neelu, Malav, Manoj Kumar, Bayad, Himanshu Chhagan, Sood, Akshay, Abraham, Leena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996485/
https://www.ncbi.nlm.nih.gov/pubmed/36911430
http://dx.doi.org/10.4103/aian.aian_543_22
_version_ 1784903053427605504
author Khanna, Sanat Kumar
Khanna, Neelu
Malav, Manoj Kumar
Bayad, Himanshu Chhagan
Sood, Akshay
Abraham, Leena
author_facet Khanna, Sanat Kumar
Khanna, Neelu
Malav, Manoj Kumar
Bayad, Himanshu Chhagan
Sood, Akshay
Abraham, Leena
author_sort Khanna, Sanat Kumar
collection PubMed
description CONTEXT: COVID-19 pandemic continues to be a serious threat to humanity even after the last 2.5 years and multiple reported waves. Post-COVID-19 cognitive impairment has a detrimental effect on the quality of life, education, occupation, psychosocial as well as adaptive functioning and independence. AIMS AND OBJECTIVE: Profiling the cognitive impairment in the mild COVID-19 recovered patients. SETTINGS AND DESIGN: Interview-based case-control study. MATERIALS AND METHODS: This study was conducted at a secondary healthcare center in a hilly region of north India. Group A included mild COVID-19 recovered patients and Group B included local non-COVID healthy individuals. Both groups of participants were interviewed using Montreal Cognitive Assessment (MoCA) to identify global and domain-wise cognitive impairment. STATISTICS USED: Descriptive statistics were used to analyze the demographic and clinical variables. The Chi-square test was used to evaluate these results and statistical analysis was done using the Statistical Package for Social Sciences (version 23) program. RESULTS: A total of 284 individuals were enrolled in our study, equally split into Groups A (cases) and B (controls). No global cognitive decline was found in any participant. However, 40 cases scored low on MoCA. The decrease in domain-wise cognitive function was statistically significant for visuospatial skill/executive function and attention. CONCLUSION: Our results have demonstrated that there is domain-wise cognitive impairment associated with mild COVID-19 disease. We recommend lowering the threshold of the MoCA to identify the early cognitive impairment and the inclusion of detailed cognitive assessment in post-COVID-19 follow-ups to initiate early cognitive rehabilitation among these patients.
format Online
Article
Text
id pubmed-9996485
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-99964852023-03-10 Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India Khanna, Sanat Kumar Khanna, Neelu Malav, Manoj Kumar Bayad, Himanshu Chhagan Sood, Akshay Abraham, Leena Ann Indian Acad Neurol Original Article CONTEXT: COVID-19 pandemic continues to be a serious threat to humanity even after the last 2.5 years and multiple reported waves. Post-COVID-19 cognitive impairment has a detrimental effect on the quality of life, education, occupation, psychosocial as well as adaptive functioning and independence. AIMS AND OBJECTIVE: Profiling the cognitive impairment in the mild COVID-19 recovered patients. SETTINGS AND DESIGN: Interview-based case-control study. MATERIALS AND METHODS: This study was conducted at a secondary healthcare center in a hilly region of north India. Group A included mild COVID-19 recovered patients and Group B included local non-COVID healthy individuals. Both groups of participants were interviewed using Montreal Cognitive Assessment (MoCA) to identify global and domain-wise cognitive impairment. STATISTICS USED: Descriptive statistics were used to analyze the demographic and clinical variables. The Chi-square test was used to evaluate these results and statistical analysis was done using the Statistical Package for Social Sciences (version 23) program. RESULTS: A total of 284 individuals were enrolled in our study, equally split into Groups A (cases) and B (controls). No global cognitive decline was found in any participant. However, 40 cases scored low on MoCA. The decrease in domain-wise cognitive function was statistically significant for visuospatial skill/executive function and attention. CONCLUSION: Our results have demonstrated that there is domain-wise cognitive impairment associated with mild COVID-19 disease. We recommend lowering the threshold of the MoCA to identify the early cognitive impairment and the inclusion of detailed cognitive assessment in post-COVID-19 follow-ups to initiate early cognitive rehabilitation among these patients. Wolters Kluwer - Medknow 2022 2022-12-03 /pmc/articles/PMC9996485/ /pubmed/36911430 http://dx.doi.org/10.4103/aian.aian_543_22 Text en Copyright: © 2022 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Khanna, Sanat Kumar
Khanna, Neelu
Malav, Manoj Kumar
Bayad, Himanshu Chhagan
Sood, Akshay
Abraham, Leena
Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India
title Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India
title_full Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India
title_fullStr Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India
title_full_unstemmed Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India
title_short Profiling Cognitive Impairment in Mild COVID-19 Patients: A Case-Control Study at a Secondary Healthcare Centre in the Hilly Region of North India
title_sort profiling cognitive impairment in mild covid-19 patients: a case-control study at a secondary healthcare centre in the hilly region of north india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996485/
https://www.ncbi.nlm.nih.gov/pubmed/36911430
http://dx.doi.org/10.4103/aian.aian_543_22
work_keys_str_mv AT khannasanatkumar profilingcognitiveimpairmentinmildcovid19patientsacasecontrolstudyatasecondaryhealthcarecentreinthehillyregionofnorthindia
AT khannaneelu profilingcognitiveimpairmentinmildcovid19patientsacasecontrolstudyatasecondaryhealthcarecentreinthehillyregionofnorthindia
AT malavmanojkumar profilingcognitiveimpairmentinmildcovid19patientsacasecontrolstudyatasecondaryhealthcarecentreinthehillyregionofnorthindia
AT bayadhimanshuchhagan profilingcognitiveimpairmentinmildcovid19patientsacasecontrolstudyatasecondaryhealthcarecentreinthehillyregionofnorthindia
AT soodakshay profilingcognitiveimpairmentinmildcovid19patientsacasecontrolstudyatasecondaryhealthcarecentreinthehillyregionofnorthindia
AT abrahamleena profilingcognitiveimpairmentinmildcovid19patientsacasecontrolstudyatasecondaryhealthcarecentreinthehillyregionofnorthindia